> News
 > MaaT Pharma Receives U.S. FDA Response
News
03/02/2023

MaaT Pharma Receives U.S. FDA Response

Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022.

Access the press release

 

Our news

News
24/08/2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
> READ
News
14/05/2024
The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector
> READ
Events
19/01/2023
Microbiota & Health Day 2023
> READ
> See all news